Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 627380, 9 pages
http://dx.doi.org/10.1155/2014/627380
Research Article

Activation of the AT1R/HIF-1α/ACE Axis Mediates Angiotensin II-Induced VEGF Synthesis in Mesenchymal Stem Cells

Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Department of Pharmacology, Nanjing Medical University, Nanjing 210029, China

Received 30 June 2014; Revised 16 August 2014; Accepted 17 August 2014; Published 20 October 2014

Academic Editor: Ken-ichi Isobe

Copyright © 2014 Chao Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. B. Strawn, R. S. Richmond, E. A. Tallant, P. E. Gallagher, and C. M. Ferrario, “Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells,” British Journal of Haematology, vol. 126, no. 1, pp. 120–126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Schächinger, B. Assmus, M. B. Britten et al., “Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial,” Journal of the American College of Cardiology, vol. 44, no. 8, pp. 1690–1699, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Nagaya, K. Kangawa, T. Itoh et al., “Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy,” Circulation, vol. 112, no. 8, pp. 1128–1135, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Uemura, M. Xu, N. Ahmad, and M. Ashraf, “Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling,” Circulation Research, vol. 98, no. 11, pp. 1414–1421, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Gnecchi, H. He, N. Noiseux et al., “Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement,” The FASEB Journal, vol. 20, no. 6, pp. 661–669, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R.-Z. Shi, J.-C. Wang, S.-H. Huang, X.-J. Wang, and Q.-P. Li, “Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells,” Experimental Cell Research, vol. 315, pp. 10–15, 2009. View at Publisher · View at Google Scholar
  7. R. Yasumatsu, T. Nakashima, M. Masuda et al., “Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells,” Journal of Cancer Research and Clinical Oncology, vol. 130, no. 10, pp. 567–573, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. O. V. Volpert, W. F. Ward, M. W. Lingen et al., “Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats,” Journal of Clinical Investigation, vol. 98, no. 3, pp. 671–679, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Yoshiji, S. Kuriyama, M. Kawata et al., “The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor,” Clinical Cancer Research, vol. 7, no. 4, pp. 1073–1078, 2001. View at Google Scholar · View at Scopus
  10. S.-I. Hii, D. L. Nicol, D. C. Gotley, L. C. Thompson, M. K. Green, and J. R. Jonsson, “Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma,” British Journal of Cancer, vol. 77, no. 6, pp. 880–883, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. H. A. Arafat, Q. Gong, G. Chipitsyna, A. Rizvi, C. T. Saa, and C. J. Yeo, “Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma,” Journal of the American College of Surgeons, vol. 204, no. 5, pp. 996–1005, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Yoshiji, S. Kuriyama, and H. Fukui, “Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma: possible role of vascular endothelial growth factor,” Tumor Biology, vol. 23, no. 6, pp. 348–356, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. C. W. Pugh and P. J. Ratcliffe, “Regulation of angiogenesis by hypoxia: role of the HIF system,” Nature Medicine, vol. 9, no. 6, pp. 677–684, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Fukuda, K. Hirota, F. Fan, Y. D. Jung, L. M. Ellis, and G. L. Semenza, “Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells,” The Journal of Biological Chemistry, vol. 277, no. 41, pp. 38205–38211, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Fukuda, B. Kelly, and G. L. Semenza, “Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1,” Cancer Research, vol. 63, no. 9, pp. 2330–2334, 2003. View at Google Scholar · View at Scopus
  16. G. S. Erwin, P. R. Crisostomo, Y. Wang et al., “Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia,” Journal of Surgical Research, vol. 152, no. 2, pp. 319–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. D. E. Richard, E. Berra, and J. Pouyssegur, “Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells,” The Journal of Biological Chemistry, vol. 275, no. 35, pp. 26765–26771, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. A. A. Kazi and R. D. Koos, “Estrogen-induced activation of hypoxia-inducible factor-1α, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway,” Endocrinology, vol. 148, no. 5, pp. 2363–2374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Zhang, Y. Wu, M. Zhao et al., “Role of HIF-1α in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 297, no. 4, pp. L631–L640, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Y. Hahn, H. J. Cho, H. J. Kang et al., “Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction,” Journal of the American College of Cardiology, vol. 51, no. 9, pp. 933–943, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Schling and T. Schäfer, “Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity,” The Journal of Biological Chemistry, vol. 277, no. 50, pp. 48066–48075, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. M.-S. Tsai, S.-M. Hwang, K.-D. Chen et al., “Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow,” Stem Cells, vol. 25, no. 10, pp. 2511–2523, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Katsuda, R. Tsuchiya, N. Kosaka et al., “Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes,” Scientific Reports, vol. 3, article no. 1197, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Schunkert, J. R. Ingelfinger, A. T. Hirsch et al., “Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II,” Circulation Research, vol. 72, no. 2, pp. 312–318, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Sadjadi, G. L. Kramer, C.-H. Yu, M. B. Welborn III, and J. G. Modrall, “Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism,” Journal of Surgical Research, vol. 129, no. 2, pp. 272–277, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. L.-X. Zou, J. D. Imig, A. M. von Thun, A. Hymel, H. Ono, and L. G. Navar, “Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats,” Hypertension, vol. 28, no. 4, pp. 669–677, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. E. L. Pagé, G. A. Robitaille, J. Pouysségur, and D. E. Richard, “Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms,” The Journal of Biological Chemistry, vol. 277, pp. 48403–48409, 2002. View at Publisher · View at Google Scholar
  28. E. Sánchez-López, A. F. López, V. Esteban et al., “Angiotensin II regulates vascular endothelial growth factor via hypoxia-inducible factor-1α induction and redox mechanisms in the kidney,” Antioxidants and Redox Signaling, vol. 7, no. 9-10, pp. 1275–1284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Krick, J. Hänze, B. Eul et al., “Hypoxia-driven proliferation of human pulmonary artery fibroblasts: cross-talk between HIF-1α and an autocrine angiotensin system,” The FASEB Journal, vol. 19, no. 7, pp. 857–859, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Zhang, L. Hu, C. Liu, L. Wang, and Q. Li, “Involvement of signal transducer and activator of transcription 3 in angiotensin II—upregulated vascular endothelial growth factor production in mesenchymal stem cells,” Acta Universitatis Medicinalis Nanjing (Natural Science), vol. 32, pp. 891–895, 2012. View at Google Scholar
  31. M. Wang, J. Tan, A. Coffey, J. Fehrenbacher, B. R. Weil, and D. R. Meldrum, “Signal transducer and activator of transcription 3-stimulated hypoxia inducible factor-1α mediates estrogen receptor-α-induced mesenchymal stem cell vascular endothelial growth factor production,” Journal of Thoracic and Cardiovascular Surgery, vol. 138, no. 1, pp. 163.e1–171.e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. J. E. Jung, H. G. Lee, I. H. Cho et al., “STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells,” The FASEB Journal, vol. 19, no. 10, pp. 1296–1298, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. Q. Xu, J. Briggs, S. Park et al., “Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways,” Oncogene, vol. 24, no. 36, pp. 5552–5560, 2005. View at Publisher · View at Google Scholar · View at Scopus